Inhalation therapy of AT-H201 in COVID-19 patients 1 AT-H201 constituents collectively are the most potent inhibitors of SARS-CoV-2 infectivity in VERO cells identified and mechanistically act as a chemical vaccine: Human safety data support rapid clinical development as inhaled therapy for COVID-19
Autor: | Quay, Steven C, Shu-Chih Chen, Rea, Janet, H Lawrence Remmel |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
DOI: | 10.13140/rg.2.2.35409.15207 |
Databáze: | OpenAIRE |
Externí odkaz: |